Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Yarrow Bioscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Yarrow Bioscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wong Roderick | 10% Owner | 266,307Indirect | Jul 30, 2026 | 1 |
| RTW Fund Group GP, LLC | 10% Owner | 266,307Indirect | Jul 30, 2026 | 1 |
| Ashiya Mona | Director | – | Jul 29, 2026 | 1 |
| Zeronda Tyler | Director | 74,918 | Jul 29, 2026 | 6 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | 95,944 | Jul 24, 2026 | 5 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | 95,918 | Jul 24, 2026 | 5 |
| Domzalski David | PRESIDENT AND CEO | 347,174 | Jul 24, 2026 | 6 |
| Lepore Patrick G | Director | 51,472 | Dec 15, 2025 | 1 |
| Barbari Sharon | Director | – | Dec 15, 2025 | 1 |
| Basta Steven L | Director | – | Dec 15, 2025 | 1 |
| Sandoval Elisabeth | Director | – | Dec 15, 2025 | 1 |
| Bruno Anthony D | Director | – | Dec 13, 2024 | 0 |
| Borowski Christine | Director | – | Dec 13, 2024 | 0 |
| Edelman Joseph | 10% Owner | 4,935,057Indirect | Aug 18, 2021 | 0 |
| Perceptive Advisors LLC | 10% Owner | 4,935,057Indirect | Aug 18, 2021 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 4,935,057Indirect | Aug 18, 2021 | 0 |
| Bright Rex | Director | – | Jul 20, 2021 | 0 |
| Wiley Matthew T. | Chief Commercial Officer | 109,246 | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 (view filing) | Jan 15 | 1 day | Lepore Patrick GDirector | PPurchase | +15.0K | $2.92 | +$43.8K | +41.1%51.5K after | |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Lepore Patrick GDirector | PPurchase | +13.0K | $3.91 | +$50.8K | +55.4%36.5K after | |
| Mar 22, 2023 (view filing) | Mar 20 | 2 days | Lepore Patrick GDirector | PPurchase | +20.0K | $2.48 | +$49.6K | +576.0%23.5K after | |
| Mar 22, 2023 (view filing) | Mar 20 | 2 days | Harsch MutyaChief Legal Officer and GC | PPurchase | +10.0K | $2.50 | +$25.0K | +78.6%22.7K after | |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Lepore Patrick GDirector | PPurchase | +12.5K | $1.02 | +$12.8K | +25.0%62.5K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Lepore Patrick GDirector | PPurchase | +12.5K | $1.60 | +$20.0K | +33.3%50.0K after | |
| Aug 18, 2021 (view filing)7:19 PM ET | Aug 16 | 2 days | Edelman Joseph and 2 others10% Owner | SSale | −250.0K | $1.74 | −$435.0K | −4.8%4.94M after | |
| Aug 17, 2021 (view filing)4:46 PM ET | Aug 13 | 4 days | Edelman Joseph and 2 others10% Owner | SSale | −250.0K | $1.84 | −$460.0K | −4.6%5.19M after | |
| Aug 16, 2021 (view filing)6:24 PM ET | Aug 12 | 4 days | Edelman Joseph and 2 others10% Owner | SSale | −338.9K | $2.23 | −$755.7K | −5.9%5.44M after |